Maria Mar Hernandez Guillamon Senior Researcher, Neurovascular Research Lab, VHIR. Instituciones de las que forman parte Investigador/a principal Enfermedades Neurovasculares Vall Hebron Institut de Recerca Twitter Maria Mar Hernandez Guillamon Twitter Instituciones de las que forman parte Investigador/a principal Enfermedades Neurovasculares Vall Hebron Institut de Recerca Senior Researcher, Neurovascular Research Lab, VHIR.
Dr. Mar Hernández-Guillamon has dedicated her career to the study of cerebral amyloid angiopathy (CAA) and other pathologies associated with the deposition of amyloid-beta (Abeta). In 2013, she was awarded by Carlos III Spanish Health Institute with the Miguel Servet contract to establish the Cerebral Amyloidosis line of research at VHIR. Her group has positioned in forefront of the Abeta-pathologies field, studying the molecular mechanisms involved in the Abeta transport and metabolism using in vitro and in vivo models. Her lab has also dedicated to the clinical research and discovery of biomarkers associated with CAA and other cerebrovascular diseases. The translational research developed by Dr. Hernandez-Guillamon's group has allowed the achievement of important aims to date, as demonstrated by the scientific production obtained (h-index= 35, 80 publications, >3700 citations) and the continuous leadership of national and international projects.
Proyectos INVICTUS IP: Joan Montaner Villalonga Colaboradores: Marta Aurora Rubiera Del Fueyo, Jorge Pagola Pérez Blanca, INVICTUS, José Alvarez Sabin, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, INVICTUS, Marc Ribó Jacobi, Maria Pilar Delgado Martínez, Carlos Molina Cateriano, Anna Rosell Novel, David Rodriguez Luna, Mª Ángeles Muchada López, Estevo Santamarina Pérez Entidad financiadora: Instituto de Salud Carlos III Financiación: 247695.66 Referencia: RD12/0014/0005 Duración: 01/01/2013 - 31/03/2017 Role of Apolipoproteins (ApoE, ApoJ and ApoA-1) in Cerebral Amyloid Angiopathy: study of â-amyloid traffic across the blood brain barrier IP: Maria Mar Hernandez Guillamon Colaboradores: - Entidad financiadora: Instituto de Salud Carlos III Financiación: 119290 Referencia: CP12/03259 Duración: 01/01/2013 - 31/01/2016 Role of Apolipoproteins (ApoE, ApoJ and ApoA-1) in Cerebral Amyloid Angiopathy: study of â-amyloid traffic across the blood brain barrier IP: Joan Montaner Villalonga Colaboradores: Maria Mar Hernandez Guillamon, Laia Perez Lasarte Entidad financiadora: Instituto de Salud Carlos III Financiación: 202500 Referencia: MS12/03259 Duración: 01/01/2013 - 31/12/2017 Estada al Dpt. de Patologia del New York University Medical School IP: Joan Montaner Villalonga Colaboradores: Maria Mar Hernandez Guillamon Entidad financiadora: Instituto de Salud Carlos III Financiación: 1800 Referencia: ESTSB-2010-01 Duración: 11/05/2010 - 14/07/2010 Paginación Primera página « Página anterior ‹ … Página 4 Página 5 Página actual 6 Página 7 Página 8 … Siguiente página › Última página »
